Animesh D Pardanani, MBBS, PhD

  • 19491 Citations
  • 77 Scopus h-Index
1993 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Animesh D Pardanani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Primary Myelofibrosis Medicine & Life Sciences
Systemic Mastocytosis Medicine & Life Sciences
Mutation Medicine & Life Sciences
Polycythemia Vera Medicine & Life Sciences
Essential Thrombocythemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Myeloproliferative Disorders Medicine & Life Sciences
Janus Kinase 2 Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2020

Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience

Shi, M., Rech, K. L., Otteson, G. E., Horna, P., Olteanu, H., Pardanani, A., Chen, D. & Jevremovic, D., Feb 2020, In : Annals of Diagnostic Pathology. 44, 151412.

Research output: Contribution to journalReview article

Lymphoproliferative Disorders
T-Lymphocyte Gene Rearrangement
T-Cell Receptor Genes
5 Citations (Scopus)

3023 Mayo Clinic Patients With Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Szuber, N., Mudireddy, M., Nicolosi, M., Penna, D., Vallapureddy, R. R., Lasho, T. L., Finke, C., Begna, K., Elliott, M. A., Hook, C. C., Wolanskyj, A. P., Patnaik, M. M., Hanson, C. A., Ketterling, R. P., Sirhan, S., Pardanani, A. D., Gangat, N., Busque, L. & Tefferi, A., Jan 1 2019, In : Mayo Clinic proceedings.

Research output: Contribution to journalArticle

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis
1 Citation (Scopus)

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

Gangat, N., Phelps, A., Lasho, T. L., Finke, C. M., Vallapureddy, R., Hanson, C. A., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 11.

Research output: Contribution to journalLetter


Calculator-free point-of-care prognostication in myelodysplastic syndromes

Tefferi, A., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Gangat, N., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

Point-of-Care Systems
Myelodysplastic Syndromes
5 Citations (Scopus)

Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation

Patnaik, M. M., Pophali, P. A., Lasho, T. L., Finke, C. M., Horna, P., Ketterling, R. P., Gangat, N., Mangaonkar, A. A., Pardanani, A. D. & Tefferi, A., Jun 1 2019, In : Haematologica. 104, 6, p. e236-e239

Research output: Contribution to journalLetter

Open Access
Leukemia, Myelomonocytic, Chronic